Literature DB >> 19397930

A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication.

Michaela Iro1, Jeroen Witteveldt, Allan G N Angus, Ilka Woerz, Artur Kaul, Ralf Bartenschlager, Arvind H Patel.   

Abstract

The human pathogen hepatitis C virus (HCV) is associated with chronic liver disease. The recent development of the cell culture infectious HCV (HCVcc) system has opened up avenues for detailed studies on the life cycle of the virus and its interaction with the host cell. Current methods to quantitate virus infectivity in cell culture are time-consuming and labor-intensive. This study describes the generation of a cell-based secreted alkaline phosphatase (SEAP) reporter assay to facilitate in vitro studies of HCV infection and replication. This assay is based on a novel reporter cell line stably expressing the enhanced green fluorescent protein (EGFP) fused in-frame to the secreted alkaline phosphatase via a recognition sequence of the viral NS3/4A serine protease. The SEAP reporter from a similar construct has previously been shown to be released from the fusion protein and be secreted into the extracellular culture medium following cleavage by the viral NS3/4A protease. The reporter cell line enabled rapid and sensitive quantification of HCV infection and viral replication in cell culture. The utility of this system for investigating virus entry, and for high throughput screening of entry inhibitors and other antiviral compounds was demonstrated using several inter- and intra-genotypic chimeras of HCV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19397930     DOI: 10.1016/j.antiviral.2009.04.007

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  29 in total

1.  A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle.

Authors:  Karuppiah Chockalingam; Rudo L Simeon; Charles M Rice; Zhilei Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

2.  Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody.

Authors:  Jane A Potter; Ania M Owsianka; Nathan Jeffery; David J Matthews; Zhen-Yong Keck; Patrick Lau; Steven K H Foung; Garry L Taylor; Arvind H Patel
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

Review 3.  Strategies for antiviral screening targeting early steps of virus infection.

Authors:  Tao Peng
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

Review 4.  Hepatitis C virus experimental model systems and antiviral drug research.

Authors:  Susan L Uprichard
Journal:  Virol Sin       Date:  2010-07-28       Impact factor: 4.327

5.  Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps.

Authors:  Viet Loan Dao Thi; Christelle Granier; Mirjam B Zeisel; Maryse Guérin; Jimmy Mancip; Ophélia Granio; François Penin; Dimitri Lavillette; Ralf Bartenschlager; Thomas F Baumert; François-Loïc Cosset; Marlène Dreux
Journal:  J Biol Chem       Date:  2012-07-05       Impact factor: 5.157

6.  Lucidone suppresses hepatitis C virus replication by Nrf2-mediated heme oxygenase-1 induction.

Authors:  Wei-Chun Chen; Sheng-Yang Wang; Chien-Chih Chiu; Chin-Kai Tseng; Chun-Kuang Lin; Hui-Chun Wang; Jin-Ching Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-12-17       Impact factor: 5.191

7.  Persistent growth of a human plasma-derived hepatitis C virus genotype 1b isolate in cell culture.

Authors:  Erica Silberstein; Kathleen Mihalik; Laura Ulitzky; Ewan P Plant; Montserrat Puig; Sara Gagneten; Mei-ying W Yu; Neerja Kaushik-Basu; Stephen M Feinstone; Deborah R Taylor
Journal:  PLoS Pathog       Date:  2010-05-20       Impact factor: 6.823

8.  Host-encoded reporters for the detection and purification of multiple enveloped viruses.

Authors:  Robin Ketteler; Vesselin Tomov; Alina Neunkirchner; Qiang Xie; Winfried F Pickl; Brian Seed
Journal:  J Virol Methods       Date:  2010-04-23       Impact factor: 2.014

Review 9.  New hepatitis C virus drug discovery strategies and model systems.

Authors:  Snawar Hussain; Naina Barretto; Susan L Uprichard
Journal:  Expert Opin Drug Discov       Date:  2012-08-04       Impact factor: 6.098

10.  Development of NS3/4A protease-based reporter assay suitable for efficiently assessing hepatitis C virus infection.

Authors:  Kao-Lu Pan; Jin-Ching Lee; Hsing-Wen Sung; Teng-Yuang Chang; John T-A Hsu
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.